{"nct_id":"NCT02831491","title":"A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer","status":"WITHDRAWN","status_verified_date":"2020-06","start_date":"2016-11","start_date_type":null,"primary_completion_date":"2017-07","primary_completion_date_type":"ESTIMATED","completion_date":"2018-01","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["LLY"]}